Evidence map›Paper›PMID 36519786›Full record

ArticleProtein science : a publication of the Protein Society2023

The MECP2-TRD domain interacts with the DNMT3A-ADD domain at the H3-tail binding site.

Stefan Kunert, Verena Linhard, Sara Weirich, Michel Choudalakis, Florian Osswald, Lisa Krämer, Anja R Köhler, Alexander Bröhm, Jan Wollenhaupt, Harald Schwalbe and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The MECP2-TRD domain interacts with the DNMT3A-ADD domain at the H3-tail binding site.Protein science : a publication of the Protein Society · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Stefan KunertInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Verena LinhardCenter for Biomolecular Magnetic Resonance (BMRZ), Institute for Organic Chemistry and Chemical Biology, Goethe University, Frankfurt, Germany.
Sara WeirichInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Michel ChoudalakisInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Florian OsswaldInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Lisa KrämerInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Anja R KöhlerInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Alexander BröhmInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.
Jan WollenhauptMacromolecular Crystallography Group, Helmholtz-Zentrum Berlin, Berlin, Germany.
Harald SchwalbeCenter for Biomolecular Magnetic Resonance (BMRZ), Institute for Organic Chemistry and Chemical Biology, Goethe University, Frankfurt, Germany.
Albert JeltschInstitute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.ORCID 0000-0001-6113-9290
University of Stuttgart · DEGoethe University Frankfurt · DEHelmholtz-Zentrum Berlin für Materialien und Energie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DNMT3A DNA methyltransferase and MECP2 methylation reader are highly expressed in neurons. Both proteins interact via their DNMT3A-ADD and MECP2-TRD domains, and the MECP2 interaction regulates the activity and subnuclear localization of DNMT3A. Here, we mapped the interface of both domains using peptide SPOT array binding, protein pull-down, equilibrium peptide binding assays, and structural analyses. The region D529-D531 on the surface of the ADD domain was identified as interaction point with the TRD domain. This includes important residues of the histone H3 N-terminal tail binding site to the ADD domain, explaining why TRD and H3 binding to the ADD domain is competitive. On the TRD domain, residues 214-228 containing K219 and K223 were found to be essential for the ADD interaction. This part represents a folded patch within the otherwise largely disordered TRD domain. A crystal structure analysis of ADD revealed that the identified H3/TDR lysine binding pocket is occupied by an arginine residue from a crystallographic neighbor in the ADD apoprotein structure. Finally, we show that mutations in the interface of ADD and TRD domains disrupt the cellular interaction of both proteins in NIH3T3 cells. In summary, our data show that the H3 peptide binding cleft of the ADD domain also mediates the interaction with the MECP2-TRD domain suggesting that this binding site may have a broader role also in the interaction of DNMT3A with other proteins leading to complex regulation options by competitive and PTM specific binding.

Indexed as

DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AMethyl-CpG-Binding Protein 2Binding SitesDNA MethylationHistonesHumansNIH 3T3 CellsPeptidesProtein BindingDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AHistonesMethyl-CpG-Binding Protein 2PeptidesDNA methylationDNMT3AMECP2protein/protein interaction

Identifiers

PMID36519786
PMCPMC9798253
OpenAlexW4311588653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.